Cresco Labs Inc. (CRLBF)
OTCMKTS · Delayed Price · Currency is USD
0.9850
-0.0650 (-6.19%)
Sep 12, 2025, 3:59 PM EDT
Cresco Labs Market Cap
Cresco Labs has a market cap or net worth of $352.72 million as of September 12, 2025. Its market cap has decreased by -31.73% in one year.
Market Cap
352.72M
Enterprise Value
747.08M
Revenue
677.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.99
Market Cap Chart
Since December 3, 2018, Cresco Labs's market cap has decreased from 627.84M to 352.72M, a decrease of -43.82%. That is a compound annual growth rate of -8.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 352.72M | 10.22% |
| Dec 31, 2024 | 320.01M | -30.65% |
| Dec 29, 2023 | 461.48M | -15.53% |
| Dec 30, 2022 | 546.30M | -71.66% |
| Dec 31, 2021 | 1.93B | -17.69% |
| Dec 31, 2020 | 2.34B | 148.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 736.80M |
| Tian'an Technology Group | 732.84M |
| Glass House Brands | 585.86M |
| CytoDyn | 424.27M |
| Northwest Biotherapeutics | 378.39M |
| American Oncology Network | 346.29M |